The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
Infections : The treated patients must monitor the injection site/s for signs of infections, such as increased redness, warmth, or pain
Figure 4 Effects on Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS), which is mainly manifested as sparse ovulation or non-ovulation, high levels of androgens, ovarian polycystic changes, obesity, and infertility, is the most common endocrine and metabolic disorder in women of childbearing age (139)
In one clinical trial , 86% of participants without type 2 diabetes lost at least 5% of their body weight after 68 weeks but that also means nearly 14% of people lost less than that
It will be helpful to anybody who utilizes it, including me
[28] [29] Call 999 or go to A&E immediately if you experience: Severe chest pain or symptoms of a serious allergic reaction Severe, sudden vision problems (possible acute angle-closure glaucoma with topiramate) Severe, persistent abdominal pain with or without vomiting (possible pancreatitis) Contact your GP urgently or call NHS 111 if you experience: Persistent nausea, vomiting, or abdominal pain Right upper abdominal pain, fever or jaundice (possible gallbladder disease) Signs of dehydration (dark urine, dizziness, reduced urination) Significant increases in heart rate or palpitations Mood changes, depression, or thoughts of self-harm Symptoms of hypoglycaemia (if diabetic): trembling, sweating, confusion Contact your GP or specialist if: You are considering combining weight-loss medications Current medication is not producing expected results You experience troublesome side effects from prescribed treatments You have obtained medications from unregulated sources You require support with weight management strategies Transparent communication with healthcare professionals ensures safe, effective, and personalised approaches to achieving and maintaining a healthy weight
